Esava Cream contains Ketoconazole 2% w/w, an imidazole antifungal agent effective in the treatment of various superficial fungal infections of the skin. Ketoconazole acts by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. Esava Cream is indicated for the management of dermatophytosis, candidiasis, and pityriasis versicolor. It is also effective against seborrheic dermatitis due to its antifungal and anti-inflammatory properties. The cream should be applied topically to the affected area once or twice daily, depending on the severity of the infection, and treatment duration typically ranges from 2 to 4 weeks. Patients are advised to cleanse and dry the affected area thoroughly before application. Esava Cream is generally well tolerated; however, mild local irritation, burning sensation, or itching may occur in some cases. It is contraindicated in individuals with known hypersensitivity to ketoconazole or any cream excipients. Caution is advised when applying near mucous membranes or broken skin. Systemic absorption is minimal, reducing the risk of systemic side effects. Esava Cream should be used under medical supervision to ensure appropriate diagnosis and treatment monitoring.